help button home button Am J Pathol Epitomics, Inc.
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Niki, T.
Right arrow Articles by Hirohashi, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Niki, T.
Right arrow Articles by Hirohashi, S.
(American Journal of Pathology. 2002;160:1129-1141.)
© 2002 American Society for Investigative Pathology

Regular Articles

Frequent Co-Localization of Cox-2 and Laminin-5 {gamma}2 Chain at the Invasive Front of Early-Stage Lung Adenocarcinomas

Toshiro Niki*, Takashi Kohno{dagger}, Sanae Iba*, Yasumitsu Moriya{ddagger}, Yoko Takahashi§, Miyuki Saito§, Arafumi Maeshima*, Tesshi Yamada*, Yoshihiro Matsuno*, Masashi Fukayama§, Jun Yokota{dagger} and Setsuo Hirohashi*

From the Pathology*
andBiology{dagger}
Divisions, National CancerCenter Research Institute, Tokyo; the Diagnostic Pathology, ClinicalLaboratory Division,{ddagger}
National Cancer CenterHospital, Tokyo; and the Department of HumanPathology,§
Faculty of Medicine, the Universityof Tokyo, Tokyo, Japan

Laminin-5 is an extracellular matrix protein that plays a key role in cell migration and tumor invasion. Cox-2 is an induced isoform of cyclooxygenases that plays an important role in carcinogenesis, suppression of apoptosis, angiogenesis, and metastasis of colon cancer. We report frequent co-expression of cox-2 and laminin-5 at the invasive front of early-stage lung adenocarcinomas. We investigated the expression of cox-2 and laminin-5 immunohistochemically in 102 cases of small-sized lung adenocarcinoma (maximum dimension, 2 cm or less). Cox-2 and laminin-5 were expressed in 97 (95.1%) and 82 (80.4%) cases, respectively. Both were preferentially localized in cancer cells at the cancer-stroma interface, although cox-2 tended to show a diffuse staining pattern in some cases. A comparison of their staining patterns revealed a striking similarity in their distribution in 24 cases, and a partial overlap between their localization in another 20 cases. Moreover, an overall correlation was found between the expression levels of cox-2 and laminin-5 (P = 0.018). To gain insight into the mechanisms that regulate the expression of these proteins, we additionally studied their expression in 58 cases of stage I lung adenocarcinoma, in which p53 status was determined by immunohistochemistry, polymerase chain reaction-single strand conformation polymorphism analysis, and direct sequencing. The results showed that tumors with mutant p53 tended to express more cox-2 than those with wild-type p53 (P = 0.080). Also, tumors that overexpressed p53 had higher levels of cox-2 and laminin-5 than those without p53 overexpression (P = 0.032 and 0.047, respectively). Further immunohistochemical analysis showed that tumors that overexpressed both epidermal growth factor receptor (EGFR) and erbB-2 had higher levels of cox-2 and laminin-5 than those without concomitant overexpression of these proteins (P = 0.014 and P = 0.018, respectively). To see whether EGFR signaling is involved in cox-2 and laminin-5 expression, we further conducted in vitro analyses using six lung adenocarcinoma cell lines (A549, HLC-1, ABC-1, LC-2/ad, VMRC-LCD, and L27). Western blot analyses showed that cox-2 mRNA levels, and to a lesser extent laminin-5 {gamma}2 mRNA levels, correlated with the expression levels of erbB-2 and the phosphorylated form of MAPK/ERK-1/2 protein. The addition of transforming growth factor-{alpha} increased both cox-2 and laminin-5 {gamma}2 mRNA levels in A549, ABC-1, and L27 with different kinetics; the induction of cox-2 occurred earlier than that of laminin-5 {gamma}2. Finally, the migration of ABC-1 cells was inhibited by MAP kinase kinase inhibitor PD98059 and a selective cox-2 inhibitor NS-398. In contrast, the migration of A549 cells was inhibited by PD98059, but much less effectively by NS-398. These results suggest that co-stimulatory mechanisms may exist that increase the expression of cox-2 and laminin-5 at the invasive front of lung adenocarcinomas and that EGFR signaling could be one of the mechanisms. Further investigations are warranted concerning the role of cox-2 and laminin-5 in cancer cell invasion and the significance of p53 and EGFR signaling in the regulation of cox-2 and laminin-5 expression.




This article has been cited by other articles:


Home page
 J. Histochem. Cytochem.Home page
G. Glass, J. A. Papin, and J. W. Mandell
SIMPLE: A Sequential Immunoperoxidase Labeling and Erasing Method
J. Histochem. Cytochem., October 1, 2009; 57(10): 899 - 905.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
E. Mendez, J. R. Houck, D. R. Doody, W. Fan, P. Lohavanichbutr, T. C. Rue, B. Yueh, N. D. Futran, M. P. Upton, D. G. Farwell, et al.
A Genetic Expression Profile Associated with Oral Cancer Identifies a Group of Patients at High Risk of Poor Survival
Clin. Cancer Res., February 15, 2009; 15(4): 1353 - 1361.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
N. Koshikawa, T. Minegishi, K. Nabeshima, and M. Seiki
Development of a New Tracking Tool for the Human Monomeric Laminin-{gamma}2 Chain In vitro and In vivo
Cancer Res., January 15, 2008; 68(2): 530 - 536.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
B. U. Sehgal, P. J. DeBiase, S. Matzno, T.-L. Chew, J. N. Claiborne, S. B. Hopkinson, A. Russell, M. P. Marinkovich, and J. C. R. Jones
Integrin beta4 Regulates Migratory Behavior of Keratinocytes by Determining Laminin-332 Organization
J. Biol. Chem., November 17, 2006; 281(46): 35487 - 35498.
[Abstract] [Full Text] [PDF]

Home page
 Ann. Thorac. Surg.Home page
H. Tsubochi, N. Sato, M. Hiyama, M. Kaimori, S. Endo, Y. Sohara, and T. Imai
Combined Analysis of Cyclooxygenase-2 Expression With p53 and Ki-67 in Nonsmall Cell Lung Cancer.
Ann. Thorac. Surg., October 1, 2006; 82(4): 1198 - 1204.
[Abstract] [Full Text] [PDF]

Home page
 J. Cell Sci.Home page
E. C. Dietze, M. L. Bowie, K. Mrozek, L. E. Caldwell, C. Neal, R. J. Marjoram, M. M. Troch, G. R. Bean, K. K. Yokoyama, C. A. Ibarra, et al.
CREB-binding protein regulates apoptosis and growth of HMECs grown in reconstituted ECM via laminin-5
J. Cell Sci., November 1, 2005; 118(21): 5005 - 5022.
[Abstract] [Full Text] [PDF]

Home page
 Molecular Cancer TherapeuticsHome page
Y. Moon, F. G. Bottone Jr., M. F. McEntee, and T. E. Eling
Suppression of tumor cell invasion by cyclooxygenase inhibitors is mediated by thrombospondin-1 via the early growth response gene Egr-1
Mol. Cancer Ther., October 1, 2005; 4(10): 1551 - 1558.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
N. D. Gross, J. O. Boyle, J. D. Morrow, M. K. Williams, C. S. Moskowitz, K. Subbaramaiah, A. J. Dannenberg, and A. J. Duffield-Lillico
Levels of Prostaglandin E Metabolite, the Major Urinary Metabolite of Prostaglandin E2, Are Increased in Smokers
Clin. Cancer Res., August 15, 2005; 11(16): 6087 - 6093.
[Abstract] [Full Text] [PDF]

Home page
 CarcinogenesisHome page
L. D. Dwyer-Nield, M. C. Srebernak, B. S. Barrett, J. Ahn, P. Cosper, A. M. Meyer, L. R. Kisley, A. K. Bauer, D. C. Thompson, and A. M. Malkinson
Cytokines differentially regulate the synthesis of prostanoid and nitric oxide mediators in tumorigenic versus non-tumorigenic mouse lung epithelial cell lines
Carcinogenesis, July 1, 2005; 26(7): 1196 - 1206.
[Abstract] [Full Text] [PDF]

Home page
 CarcinogenesisHome page
S. Fang, X. Jin, R. Wang, Y. Li, W. Guo, N. Wang, Y. Wang, D. Wen, L. Wei, and J. Zhang
Polymorphisms in the MMP1 and MMP3 promoter and non-small cell lung carcinoma in North China
Carcinogenesis, February 1, 2005; 26(2): 481 - 486.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
N. Koshikawa, T. Minegishi, A. Sharabi, V. Quaranta, and M. Seiki
Membrane-type Matrix Metalloproteinase-1 (MT1-MMP) Is a Processing Enzyme for Human Laminin {gamma}2 Chain
J. Biol. Chem., January 7, 2005; 280(1): 88 - 93.
[Abstract] [Full Text] [PDF]

Home page
 CarcinogenesisHome page
A. Maciag, G. Sithanandam, and L. M. Anderson
Mutant K-rasV12 increases COX-2, peroxides and DNA damage in lung cells
Carcinogenesis, November 1, 2004; 25(11): 2231 - 2237.
[Abstract] [Full Text] [PDF]

Home page
 JCBHome page
S. Schenk, E. Hintermann, M. Bilban, N. Koshikawa, C. Hojilla, R. Khokha, and V. Quaranta
Binding to EGF receptor of a laminin-5 EGF-like fragment liberated during MMP-dependent mammary gland involution
J. Cell Biol., April 14, 2003; 161(1): 197 - 209.
[Abstract] [Full Text] [PDF]

Home page
 Pharmacol. Rev.Home page
R. Danesi, F. De Braud, S. Fogli, T. M. De Pas, A. Di Paolo, G. Curigliano, and M. Del Tacca
Pharmacogenetics of Anticancer Drug Sensitivity in Non-Small Cell Lung Cancer
Pharmacol. Rev., March 1, 2003; 55(1): 57 - 103.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
M. Dohadwala, R. K. Batra, J. Luo, Y. Lin, K. Krysan, M. Pold, S. Sharma, and S. M. Dubinett
Autocrine/Paracrine Prostaglandin E2 Production by Non-small Cell Lung Cancer Cells Regulates Matrix Metalloproteinase-2 and CD44 in Cyclooxygenase-2-dependent Invasion
J. Biol. Chem., December 20, 2002; 277(52): 50828 - 50833.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2002 by the American Society for Investigative Pathology.